| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Research Council Human Reproductive Sciences Unit (K.D.G.P., A.J.P., R.P.M.), Centre for Reproductive Biology, The Queens Medical Research Institute, Edinburgh EH16 4TJ, United Kingdom; and Western Australian Institute for Medical Research/Centre for Medical Research (K.D.G.P.), University of Western Australia, QEII Medical Centre, Nedlands, Western Australia 6009, Australia
Address all correspondence and requests for reprints to: Dr. Kevin D. G. Pfleger, Western Australian Institute for Medical Research, Ground Floor, B Block, QEII Medical Centre, Hospital Avenue, Nedlands, Western Australia 6009, Australia. E-mail: kpfleger{at}waimr.uwa.edu.au.
GnRH and its structural variants bind to GnRH receptors from different species with different affinities and specificities. By investigating chimeric receptors that combine regions of mammalian and nonmammalian GnRH receptors, a greater understanding of how different domains influence ligand binding and receptor activation can be achieved. Using human-catfish and human-chicken chimeric receptors, we demonstrate the importance of extracellular loop conformation for ligand binding and agonist potency, providing further evidence for GnRH and GnRH II stabilization of distinct active receptor conformations. We demonstrate examples of GnRH receptor gain-of-function mutations that apparently improve agonist potency independently of affinity, implicating a role for extracellular loops in stabilizing the inactive receptor conformation. We also show that entire extracellular loop substitution can overcome the detrimental effects of localized mutations, thereby demonstrating the importance of considering the conformation of entire domains when drawing conclusions from point-mutation studies. Finally, we present evidence implicating the configuration of extracellular loops 2 and 3 in combination differentiating GnRH analog binding modes. Because there are two endogenous forms of GnRH ligand but only one functional form of full-length GnRH receptor in humans, understanding how GnRH and GnRH II can elicit distinct functional effects through the same receptor is likely to provide important insights into how these ligands can have differential effects in both physiological and pathological situations.
This article has been cited by other articles:
![]() |
P. Chen and S. M. Moenter GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons Is Regulated by GnRH in a Concentration-Dependent Manner Engaging Multiple Signaling Pathways J. Neurosci., August 5, 2009; 29(31): 9809 - 9818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, C. D. MacCalman, Y.-l. Wang, and P. C. K. Leung Promotion of Human Trophoblasts Invasion by Gonadotropin-Releasing Hormone (GnRH) I and GnRH II via Distinct Signaling Pathways Mol. Endocrinol., July 1, 2009; 23(7): 1014 - 1021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |